What’s at Stake in FDA’s Hormone Attack
One patient’s story. Action Alert! We’ve been telling you for a while now about the FDA’s attack on individualized bioidentical hormone replacement therapy, particularly the threat to estriol. To recap where we are: estriol and other bioidentical hormones have been nominated to the FDA’s Demonstrably Difficult to Compound List; items that appear on the list […]